Lymphoma Treatments at Wilmot
New treatments for lymphoma are being developed continuously, while standard therapies are constantly being made safer or more effective. At the Wilmot Cancer Center, our goal is to improve upon the standard treatments, and—when necessary—offer novel therapies not available at other centers.
The Wilmot Cancer Center offers more clinical trials than any other cancer center in the region. This allows us to provide our patients with many more treatment options for all stages of cancer. At any given time, we have over 20 active clinical trials for lymphoma patients. This gives our patients access to groundbreaking treatments that are only available here.
Choosing the Wilmot Cancer Center gives patients access to promising new approaches for lymphomas that are resistant to standard treatments. Our highly specialized team of experts is experienced in selecting the treatments that would be most beneficial to you or your loved one.
Patients with lymphoma can be treated with one or more of the following approaches:
Chemotherapy uses drugs to kill cancer cells. Chemotherapy is the most frequently used treatment for lymphoma. It may be used by itself or in conjunction with other treatments.
Biologic therapies use drugs that interrupt the growth and spread of tumor cells by blocking certain molecular or biological pathways.
Radiation therapy is used in about 20% of patients with lymphoma. By using new and eloquent (is this the right word? Not sure what is meant by “eloquent” in this context.) radiation technologies, like Involved Nodal Radiation Therapy, Intensity Modulated Radiotherapy, Image Guided Radiotherapy and Stereotactic Radiotherapy, we are able to precisely tailor the shape of the radiation beam to the tumor, helping to protect healthy tissue.
Stem cell transplants may be used to replace bone marrow that was affected by lymphoma, or harmed by chemotherapy or radiation. Stem cell transplants allow doctors to use higher doses of chemotherapy or radiation in treating cancer and, in the case of allogeneic stem cell transplant, provide a new immune system to help fight the lymphoma.
Radioimmunotherapy uses radioactive substances that are paired with antibodies. The antibodies attach themselves to cancer cells so they can deliver a dose of radiation directly to those cells while minimizing harm to surrounding tissues.
Immunotherapies are drugs that use your body’s immune system to target and kill lymphoma cells. Drugs like Rituximab attach a “flag” to lymphoma cells, making it easier for your immune system to find them and kill them.